Cipla Pharma And Life Sciences Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2008.

2008 Mumbai, Maharashtra, India Active

Last Updated: December 23, 2025

About Cipla Pharma And Life Sciences Limited

Cipla Pharma And Life Sciences Limited, a active public limited company, was established on 20 August 2008 in Mumbai, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24239MH2008PLC381559. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹275.00 Cr and a paid-up capital of ₹258.71 Cr.

Formerly known as Biomab Pharmaceuticals (India) Private Limited, Cipla Biotec Private Limited. It upholds a compliant status. Employing 28 professional, Its leadership includes Anisha Naresh Udeshi (Director), Sunil Jvalaprsad Gupta (Managing Director), Jinesh Chauhan (Whole-Time Director). Past directors included Dinesh Ramniranjan Jain, Raman Parameswaran Athipotta, Geena Malhotra. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Tower A, 1St Floor, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel,, Mumbai, Maharashtra, 400013.

Company Details

CIN/LLPIN
U24239MH2008PLC381559
Registration Number
381559
Incorporation Date
20 August 2008
Authorized Capital
₹275.00 Cr
Paid-Up Capital
₹258.71 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 275.00 Cr as on 23-12-2025
Paid Up Capital ₹ 258.71 Cr as on 23-12-2025
Company Age 17 Year, 7 Months
Last Filing with ROC 31 Mar 2025

Comprehensive Company Insights

Explore comprehensive insights into Cipla Pharma And Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Cipla Pharma And Life Sciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Anisha Naresh Udeshi	Director	08 Jun 2020	Current
Sunil Jvalaprsad Gupta	Managing Director	02 Feb 2024	Current
Jinesh Chauhan	Whole-Time Director	01 Apr 2023	Current
Rajendra Kumar Chopra	Director	02 Jan 2019	Current
Raju Sunil Mistry	Additional Director	01 Jun 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	15 Apr 2011	Past
Pramod Abcsdd	Director	08 Jul 2014	Past
Pramod Abcsdd	Director	11 Nov 2021	Past
Pramod Abcsdd	Additional Director	18 Dec 2020	Past
Pramod Abcsdd	Additional Director	11 Mar 2024	Past
Pramod Abcsdd	Cfo	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cipla Pharma And Life Sciences.

Cipla Pharma And Life Sciences Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cipla Pharma And Life Sciences?

In 2023, Cipla Pharma And Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cipla Pharma And Life Sciences?

Cipla Pharma And Life Sciences has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cipla Pharma And Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cipla Pharma And Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cipla Pharma And Life Sciences

Recent Activity within the Organization

Annual General Meeting

The activity Cipla Pharma And Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Director Appointment

Progress on Gargi Sadanand Sahasrabudhe was appointed as a Company Secretary was appointed as a Company Secretary on 26 Jun 2025 & has been associated with this company since 9 months 2 days . was documented.
26 Jun 2025
Director Appointment

Progress on Raju Sunil Mistry was appointed as a Additional Director was appointed as a Additional Director on 01 Jun 2025 & has been associated with this company since 9 months 27 days . was documented.
01 Jun 2025
Balance Sheet

Cipla Pharma And Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025
Director Appointment

Progress on Sarvesh Ketan Padalkar was appointed as a Cfo was appointed as a Cfo on 25 Jun 2024 & has been associated with this company since 1 year 9 months . was documented.
25 Jun 2024
Director Appointment

Progress on Sunil Jvalaprsad Gupta was appointed as a Managing Director was appointed as a Managing Director on 02 Feb 2024 & has been associated with this company since 2 years 1 month . was documented.
02 Feb 2024

Explore recent activity and updates - View Recent Activity